Amarantus licenses a blood test under development to identify Alzheimer's; Biocartis launched its Dynamic Multi-Analyte Technology platform;

> Amarantus BioScience exercised an option to license a blood test under development designed to identify Alzheimer's at an early stage. Story

> NeuroQuest is moving toward a validation trial for novel blood-based immune biomarkers for the diagnosis of Alzheimer's disease.  Release

> Scientists have discovered a cognitive biomarker for young adolescents who are at high risk of developing depression and anxiety. Report

> Biocartis launched a new proteomic and nucleic acid platform for high quality data analysis and accurate and fast validation of biomarkers. Release

And Finally... Queen Mary, University of London, received a $1.3 million grant through the Biomarkers of Gut Function and Health program to carry out work in Zambia aimed at finding and evaluating candidate biomarkers of enteropathy. Article

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.